Sign in

CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
811591163
Phone
617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 424B3 Offering Prospectus
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. EFFECT Other Notice of Effectiveness
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. UPLOAD Other SEC-generated Letter
  10. S-3 Offering Registration Statement
  11. 8-K Event Results of operations · Regulation FD disclosure
  12. 8-K Event Executive or director change
  13. SCHEDULE 13D Stake Beneficial Ownership Report
  14. 4 Grant or award Director acquired 4,625,346 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. SCHEDULE 13G Stake Statement of Beneficial Ownership
  20. SCHEDULE 13D/A Stake Beneficial Ownership Report

Page 4 of 24 · 464 filings